ASCO 2022: Surprising News in Cancer Research
The American Society of Clinical Oncology (ASCO) just finished up its annual meeting. We have some winners coming out of the conference.
19.42 | |
19.35 | |
397 K | |
20.41 | |
18.98 | |
6.035-26.91 | |
867 M | |
43 787 K | |
0 | |
-1.56 | |
0 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
The American Society of Clinical Oncology (ASCO) just finished up its annual meeting. We have some winners coming out of the conference.
Newcomer Arcellx could rival Johnson & Johnson in multiple myeloma, an analyst said Monday as the biotech stock popped to a two-month high.
Or need any other data for equities, funds or ETFs? Send us an email and we will back to you
support@eodhistoricaldata.com